CLINICAL TRIALS
Cannabis

Formulation

CLINICAL TRIALS

ANZCTR

STATUS

NanaBis (NanoCelle CBD/THC) The buccal administration of a Cannabis sativa L./Cannabis indica L. extract as an adjunct to opioid analgesia for the management of intractable pain in patients diagnosed with advanced cancer: a safety, tolerability and exploratory end-point pilot study ACTRN12617001480370 Recruiting TBA
NanaBidial (NanoCelle CBD) The buccal administration of a Nanocelleā„¢ CBD preparation to healthy volunteers: a safety, tolerability and pharmacokinetic exploratory pilot study. ACTRN12617001491358 Recruiting
Delivery Platform

Formulation

CLINICAL TRIALS

ANZCTR

STATUS

NanoCelle CoQ10 Coenzyme Q10 Absorption Studies in Healthy Adult Volunteers ACTRN12616001037493 Recruiting Closed
NanoStat (NanoCelle Atorvastatin) A single dose, blinded, balanced, randomised, two-treatment, two period, two sequence, two-way crossover pilot study comparing the pharmacokinetics of 1 x 8 mg atorvastatin oral spray (Medlab Clinical, Australia) with 1 x 20 mg LipitorĀ® capsule (Pfizer, Australia) in healthy subjects under fasting conditions. ANZCTR TBA Recruiting TBA
Depression

Formulation

CLINICAL TRIALS

ANZCTR

STATUS

NRGBiotic A randomised placebo controlled clinical trial investigating the role of orotic acid and probiotics for the management of depression ACTRN12617000419369 Recruiting TBA
Contract for 3rd Parties

Formulation

CLINICAL TRIALS

ANZCTR

STATUS

Arbovitae Health and Wellbeing supplement A Phase IIa Double-Blind Placebo Controlled Clinical Trial Investigating the Efficacy and Safety of Arborvitae Health and Wellbeing Supplement in Improving Blood Glucose Levels in Pre-Diabetes Participants ACTRN12615000233527 Recruiting